To assess the changes of plasma asymmetric dimethylarginine (ADMA) levels and its potential associations with patient characteristics after six months of renal transplant. Subjects and methods: A prospective, descriptive study which enrolled 83 recipients at 6 months after renal transplant compared to 83 healthy people at Military Hospital 103 from March 2018 to April 2020. |